title: Danazol for myelodysplastic syndromes.
authors.forename: L
authors.initials: L
authors.lastname: Catalano
authors.forename: C
authors.initials: C
authors.lastname: Selleri
authors.forename: N
authors.initials: N
authors.lastname: Montuori
authors.forename: G
authors.initials: G
authors.lastname: Fratellanza
authors.forename: R
authors.initials: R
authors.lastname: Notaro
authors.forename: R
authors.initials: R
authors.lastname: Fontana
authors.forename: S
authors.initials: S
authors.lastname: Formisano
authors.forename: B
authors.initials: B
authors.lastname: Rotoli
mesh_terms: D001772:Blood Cell Count / Q000187:drug effects; D001792:Blood Platelets / Q000276:immunology; D003613:Danazol / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
chemical_list: D003613:Danazol